Taris Biomedical

Taris raises $18 million in Series B

Wednesday, April 13, 2011

Taris Biomedical, a drug-delivery company based in Lexington, Mass., that focuses on therapies for genitourinary diseases, has raised $18.3 million in Series B financing, according to Fierce Drug Delivery.  Investors were Third Rock Ventures, Flagship Ventures, Flybridge Capital Partners and Polaris Venture Partners.

[Read More]